A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

BACKGROUND: We evaluated the efficacy of aprepitant plus granisetron and an increased dose of dexamethasone in selected patients undergoing moderately emetogenic chemotherapy (MEC). METHODS: Nondrinking women <70 years undergoing MEC were randomly assigned to aprepitant (day 1, 125 mg; days 2 and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tanioka, M, Kitao, A, Matsumoto, K, Shibata, N, Yamaguchi, S, Fujiwara, K, Minami, H, Katakami, N, Morita, S, Negoro, S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2013
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3749572/
https://ncbi.nlm.nih.gov/pubmed/23860530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.400
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia